Literature DB >> 10627428

Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?

R Manthorpe1, C Benoni, L Jacobsson, Z Kirtava, A Larsson, R Liedholm, C Nyhagen, H Tabery, E Theander.   

Abstract

OBJECTIVES: Prospectively collected computer database information was previously assessed on a cohort of 300 patients who fulfilled the Copenhagen classification criteria for primary Sjögren's syndrome. Analysis of the clinical data showed that patients who smoked had a decreased lower lip salivary gland focus score (p<0.05). The aim of this original report is to describe the tobacco habits in patients with primary Sjögren's syndrome or stomatitis sicca only and to determine if there is a correlation between smoking habits and focus score in lower lip biopsies as well as ciculating autoantibodies and IgG.
METHODS: All living patients with primary Sjögren's syndrome or stomatitis sicca only, who were still in contact with the Sjögren's Syndrome Research Centre were asked to fill in a detailed questionnaire concerning present and past smoking habits, which was compared with smoking habits in a sex and age matched control group (n=3700) from the general population. In addition, the patients previous lower lip biopsies were blindly re-evaluated and divided by the presence of focus score (focus score = number of lymphocyte foci per 4 mm(2) glandular tissue) into those being normal (focus score </= 1) or abnormal (focus score > 1). Furthermore the cohort was divided into three groups; 10-45, 46-60 and >/= 61 years of age. Finally the focus score was related to the smoking habits. Seroimmunological (ANA; anti-SSA/Ro antibodies; anti-SSB/La antibodies; IgM-RF and IgG) samples were analysed routinely.
RESULTS: The questionnaire was answered by 98% (n=355) of the cohort and the percentage of current smokers, former smokers and historical non-smokers at the time of lower lip biopsy was not statistically different from that of the control group. Cigarette smoking at the time of lower lip biopsy is associated with lower risk of abnormal focus score (p<0.001; odds ratio 0.29, 95%CI 0.16 to 0.50). The odds ratio for having focal sialadenitis (focus score > 1) compared with having a non-focal sialadenitis or normal biopsy (focus score </= 1) was decreased in all three age groups (10-45: odds ratio 0.27, 95%CI 0.11 to 0.71; 46-60: odds ratio 0.22, 95%CI 0. 08 to 0.59; and >/= 61: odds ratio 0.36, 95%CI 0.10 to 1.43) although there was only statistical significance in the two younger age groups. Moreover, among current smokers at the time of the lower lip biopsy there was a decreasing odds ratio for an abnormal lip focus score with increasing number of cigarettes smoked per week (p trend 0.00). In the group of former smokers, which included patients that had stopped smoking up to 30 years ago, the results were in between those of the smokers and the historical non-smokers (odds ratio 0.57, 95%CI 0.34 to 0.97, compared with never smokers). Present or past smoking did not correlate with the function of the salivary glands as judged by unstimulated whole sialometry, stimulated whole sialometry or salivary gland scintigraphy. Among former smokers, the median time lapse between the first symptom of primary Sjögren's syndrome and the performance of the lower lip biopsy was approximately half as long as the median time lapse between smoking cessation and biopsy (8 versus 15 years). Hence, symptoms of Sjögren's syndrome are unlikely to have had a significant influence on smoking habits at the time of the biopsy. Among the seroimmunological results only anti-SSA/Ro and anti-SSB/La antibodies reached statistical significance in a manner similar to the way smoking influenced the focus score in lower lip biopsies. On the other hand the level of significance was consistently more pronounced for the influence of smoking on the focus score than for the influence on anti-SSA/Ro and anti-SSB/La autoantibodies.
CONCLUSION: This is believed to be the first report showing that cigarette smoking is negatively associated with focal sialadenitis-focus score >1-in lower lip biopsy in patients with primary Sjögren's syndrome. Furthermore, tobacco seems to decrea

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627428      PMCID: PMC1752994          DOI: 10.1136/ard.59.1.54

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  Sjögren's syndrome criteria.

Authors:  R Manthorpe
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  The oral component of Sjögren's syndrome: pass the scalpel and check the water.

Authors:  Ava J Wu
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

3.  Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.

Authors:  Peter Olsson; Iris L A Bodewes; Anna M Nilsson; Carl Turesson; Lennart T H Jacobsson; Elke Theander; Marjan A Versnel; Thomas Mandl
Journal:  Rheumatol Int       Date:  2019-05-28       Impact factor: 2.631

4.  HO-1 protects smokers exposed to artificial stone dust for pulmonary function tests deterioration.

Authors:  Noa Ophir; Amir Bar-Shai; Mordechai R Kramer; Ahuva Grubstein; Lilach Shani Israeli; Elizabeth Fireman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

5.  Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren`s syndrome.

Authors:  Andreas Knopf; Benedikt Hofauer; Klaus Thürmel; Reinhard Meier; Konrad Stock; Murat Bas; Naglaa Manour
Journal:  Eur Radiol       Date:  2015-04-11       Impact factor: 5.315

6.  [Labial salivary gland biopsy in Sjögren's syndrome].

Authors:  A Dankof; L Morawietz; E Feist
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

7.  Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study.

Authors:  Luisa Servioli; Gabriel Maciel; Carlotta Nannini; Cynthia S Crowson; Eric L Matteson; Divi Cornec; Alvise Berti
Journal:  J Rheumatol       Date:  2019-01-15       Impact factor: 4.666

8.  Salivary gland scintigraphy in Sjögren's syndrome and patients with sicca symptoms but without Sjögren's syndrome: the psychological profiles and predictors for salivary gland dysfunction.

Authors:  E-K Tensing; D C Nordström; S Solovieva; K-O Schauman; I Sippo-Tujunen; T Helve; S Natah; J Ma; T F Li; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Marta Perez-De-Lis; Iratxe Jimenez; Maria-Jose Blanco; Albert Bove; Maria-Jose Soto; Miriam Akasbi; Candido Diaz; Juan Sentís; Antoni Siso
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  Smoking and nicotine exposure delay development of collagen-induced arthritis in mice.

Authors:  Sofia S Lindblad; Piotr Mydel; Ing-Marie Jonsson; Robert M Senior; Andrej Tarkowski; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2009-06-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.